Naperville, IL -- (SBWire) -- 05/12/2015 --Reportstack, provider of premium market research reports announces the addition of Global Gastrointestinal OTC Drugs Market 2015-2019 market report to its offering
About gastrointestinal OTC drugs
OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
Technavio's analysts forecast the global gastrointestinal OTC drugs market to grow at a CAGR of 1.48% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global gastrointestinal OTC drugs market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of various OTC drugs available in the market for the management of gastrointestinal disorders such as:
GERD/Heartburn
Constipation
Diarrhea
Nausea due to motion sickness
Flatulence
The report presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also discusses the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.
Technavio's report, Global Gastrointestinal OTC Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and EMEA and APAC; it also covers the global gastrointestinal OTC drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Bayer
GlaxoSmithKline
Johnson & Johnson
Perrigo
Pfizer
Procter & Gamble
Other prominent vendors
Abbott
Boehringer Ingelheim
C.B. Fleet
Nestle
Omega
Purdue Pharma
Reckitt Benckiser
Sanofi
Teva Pharmaceutical
Market driver
Increase in patient population
For a full, detailed list, view our report
Market challenge
High spending on advertisement
For a full, detailed list, view our report
Market trend
Strategic alliances
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Companies Mentioned
AG, GlaxoSmithKline plc, Johnson & Johnson Ltd., Perrigo Co. plc, Pfizer Inc. and Procter & Gamble Co., Abbott, Boehringer Ingelheim, C.B. Fleet, Daewoong, Eisai, Nestle, Omega, Purdue Pharma, Reckitt Benckiser, Sanofi, Taisho, Takeda Pharmaceutical and Teva Pharmaceutical.
Complete report is available
http://www.reportstack.com/product/200436/global-gastrointestinal-otc-drugs-market-2015-2019-.html
Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
Global Gastrointestinal OTC Drugs Market 2015-2019